The National Health Surveillance Agency (Anvisa) has made an important decision by banning the sale of a dietary supplement called Insupril, which claimed to cure diabetes. This measure aims to protect the health of the population, especially considering that around 20 million Brazilians live with this chronic disease.
Main Points
- Anvisa bans the supplement Insupril, which promised a cure for diabetes.
- Diabetes is a chronic disease with no cure, only control.
- The product has no scientific proof of effectiveness.
- Reports of fraud and misleading promises circulate on social media.
What is Insupril?
Insupril is a dietary supplement that presents itself as a natural solution for diabetes. However, Anvisa clarifies that the product is not a medicine and has no scientific evidence to validate its claims of cure.
The Reality About Diabetes
Diabetes is a health condition that affects millions of people in Brazil. The disease occurs due to a lack of insulin or the body's resistance to this hormone, and there is no cure. Treatment involves strict control of blood glucose, which may include medications such as metformin, a balanced diet and physical exercise.
Fraud and Misleading Promises
A video recently circulated on social media promoting Insupril, featuring a supposed doctor who made false claims about the ineffectiveness of traditional medications. This type of misinformation is dangerous and can lead patients to abandon effective treatments in favor of unproven solutions.
Reports and Complaints
On the complaints website Reclame Aqui, several complaints were registered from consumers who faced problems with the delivery and effectiveness of Insupril. This shows that many are falling into the trap of misleading promises, which can have serious consequences for their health.
The Importance of Reliable Information
Providing accurate health information is essential. Experts such as Ana Bonassa, PhD in Science, have been working to debunk myths and misinformation about diabetes. Combating misinformation is crucial to ensuring that patients receive appropriate treatment and are not misled by fraudulent products.
Conclusion
The ban on Insupril by Anvisa is an important step in protecting public health. It is essential that the population is aware of the risks associated with products that promise miracle cures and that they seek information from reliable sources. Diabetes is a condition that requires medical monitoring and appropriate treatment, and should not be treated with unproven solutions.
Leave a comment
This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.